REGENXBIO Inc. (NASDAQ:RGNX) Q4 2024 Earnings Call Transcript March 13, 2025
REGENXBIO Inc. beats earnings expectations. Reported EPS is $-1.01, expectations were $-1.27.
Operator: Welcome everyone to the Fourth Quarter and Year End 2024 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode. To ask a question during the session, you’ll need to press star one one on your telephone. To withdraw your question, please press star one one again. Please be...
